Our team is devoted to exploring the patho/physiological mechanisms and potential translation therapy in the field of CVDs, including risk factors and adaptations in hypertension, arrhythmia and heart failure process. The recent publications are listed below: 1. Jin, J., Chen, J., & Wang, Y. (2022). Aldehyde dehydrogenase 2 and arrhythmogenesis. Heart rhythm, S1547-5271(22)01965-8. Advance online publication. 2. Xu, J., Gao, Y., Liu, C., & Wang, Y. (2022). Radiofrequency ablation for treatment of atrial fibrillation with the use of intracardiac echocardiography versus without intracardiac echocardiography: A meta-analysis of observational and randomized studies. Journal of cardiovascular electrophysiology, 33(5), 897–907. 3. Qian, N., Yang, D., Li, H., Ding, S., Yu, X., Fan, Q., Yu, Z., Ye, S., Yu, H., Wang, Y., & Pan, X. (2021). Considering Psychosocial Factors When Investigating Blood Pressure in Patients with Short Sleep Duration: A Propensity Score Matched Analysis. International journal of hypertension, 2021, 7028942. 4. Qian, Ningjing et al. “Emerging role of interleukin-13 in cardiovascular diseases: A ray of hope.” Journal of cellular and molecular medicine vol. 25,12 (2021): 5351-5357. 5. Gao, Y., Qian, N., Xu, J., & Wang, Y. (2021). The Roles of Macrophages in Heart Regeneration and Repair After Injury. Frontiers in cardiovascular medicine, 8, 744615.